RE: "SMOKING AND BREAST CANCER: RECONCILING THE EPIDEMIOLOGIC EVIDENCE BY ACCOUNTING FOR PASSIVE SMOKING AND/OR GENETIC SUSCEPTIBILITY” by Morabia, Alfredo et al.
992 Letters to the Editor
TABLE 2. Relative risks associating breast cancer with passive and active smoking*
Study
Sandier* (3)
Hirayama* (3)
Smith etal. (1)
Morabla et al. (2)
Combined
Sandier* (4)
HirayamaH
Smith etal. (1)#
Morabla et al. (2)«
Combined
No.
32
115
94
126
367
40
60
87
146
333
Cases
exposed
59
80
49
78
68
62
45
81
Controls or population
No.
exposed
Passive smoking
177
91,540
100
620
43
76
37
61
Active smoking
248
39,261
96
652
59
44
34
63
Adjusted
relative
rtskt
1.62
1.32
1.58§
2.3
1.83
1.21
2.03
2.00
3.0
2.17
95%
confidence
interval
0.76-3.44
0.83-2.09
0.81-3.10§
1.5-3.7
1.40-2.40
0.58-2.51
1.22-3.38
0.98-4.12
1.9-4.8
1.63-2.88
weight
6.7
18.0
8.5
19.0
52.2
7.2
14.8
7.5
17.9
47.4
• Passive smoking is for never smokers only. Subjects who never smoked and who were not exposed to
environmental tobacco smoke constitute the reference category for both active and passive smoking. For active
smoking, % exposed is the proportion of ever smokers to ever smokers plus non-environmental tobacco smoke-
exposed never smokers.
t Odds ratios from the case-control studies are assumed to be reasonable approximations to relative risk.
* Data obtained from Drs. Dale P. Sandier and T. Hirayama by means of personal communications and
published in two previous letters by Wells (3, 4).
§ For partner exposure only. Odds ratio for total adult exposure was 3.13 (95% Cl 0.73-13.31).
H Author's calculation based on population data in Hirayama (6) and active relative risk from T. Hirayama,
Institute of Preventive Oncology, Tokyo, Japan, personal communication, 1988.
# S.J. Smith, University of Nottingham Medical School, Nottingham, United Kingdom, personal
communication, 1996.
** Combined odds ratios for all ever smokers in table 2 of Morabia et al. (2), from A. Morabla, Hopltal Cantonal
Unlversltafre, Geneva, Switzerland, personal communication, 1997.
results indicated here. Women are known to fear breast
cancer. If breast cancer is indeed caused by cigarette smoke,
women need to know that, not only to reduce their breast
cancer risk by avoiding smoke but also to improve public
health generally through a reduced prevalence of smoking.
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RE: "SMOKING AND BREAST CANCER: RECONCIUNG THE EPIDEMIOLOGIC EVIDENCE BY ACCOUNTING
FOR PASSIVE SMOKING AND/OR GENETIC SUSCEPTIBILITY"
Wells (1) reports that four studies conducted in different
populations and with different designs consistently show
that women exposed to passive smoking as well as those
exposed to active smoking are at increased risk of breast
cancer relative to women unexposed to either. These results
are disturbing for at least two reasons. First, as mentioned
by Whidden (2), reported associations of breast cancer with
active versus nonactive smoking have, in general, been
either weakly positive or absent Second, the relation does
not appear to be related to dose of exposure to tobacco
smoke, since the combined relative risk for passive smoking
(relative risk = 1.8) is of the same magnitude as that for
active smoking (relative risk = 2.1).
These puzzling findings could, of course, be attributed
simply to a yet-undetermined bias, because they are too
aberrant compared with findings in the rest of the literature.
However, an additional study (not cited by Wells (1) or
Whidden (2)) has furthered understanding of the relation
between smoking and breast cancer risk. Ambrosone et al.
(3) found that among slow acetylators of aromatic amines
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TABLE 1. Percentage* of unexposed woman, passive smoker*, and active smokers, and relative risks of breast cancer as
approximated by odds ratios according to tobacco smoke exposure and acetylation status; hypothetical data*
Exposure
smoke
AS RapkJ acetytalors* S o w acetytetors'
Cases Controls Odds
rattot
Cases Controls Odds
ratio
Cases Controls Odds
rallo
Unexposed
Passive
Active
All
19
43
38
100
31
40
29
100
1.0-1
J 1
1.8 *Z1
0
1.5
35
35
30
100
30
40
30
100
1.0
0.8
0.9
1.0
1.0
10
48
42
100
32
40
28
100
1.0
3.8
4.8
1.0
1.9
* Prevalences of slow acetytators among cases is 0.30 for unexposed, 0.70 for passive smokers, and 0.70 for active smokers; among
controls, it Is 0.50 for each of the smoking categories,
t Derived from table 2 in Wells (1).
(rapid acetylators being better able to inactivate the poten-
tially carcinogenic tobacco compounds), the risk of breast
cancer was increased in postmenopausal women who ac-
tively smoked compared with those who never actively
smoked.
Could it be that the studies by Ambrosone et al. (3) and
the four studies pooled by Wells (1) essentially show the
same phenomenon; that is, women who develop breast
cancer as a consequence of either active or passive smoking
are more likely to be slow acetylators?
We have stratified the data reported by Wells (1) accord-
ing to NAT2 status using, when possible, information de-
rived from Ambrosone et al. (3) and from the literature
(table 1). As observed in the populations of Ambrosone et
al. and, more generally, in Caucasian populations (4), the
population prevalence of the NAT2 slow-acetylation trait is
about 50 percent We can therefore expect to find this
prevalence among population controls across all smoking
categories. Among cases, Ambrosone et al. found that about
70 percent of active smokers who developed breast cancer
were slow acetylators. We postulate that the same preva-
lence applies to passive smokers.
On the basis of these hypothetical prevalences, and as-
suming relative risks of 1.8 for passive smokers and 2.1 for
active smokers, respectively, as found by Wells (1), we can
compute the relative risks of breast cancer separately for
slow and rapid acetylators. Table 1 shows that the results
reported by Wells are compatible with the finding that
passive and active smoking increase breast cancer risk in
slow but not in rapid acetylators.
Table 1 also indicates that if we pool passive smokers
with women unexposed to either active or passive smoke to
form the reference group (vs. active smokers), the relative
risk of breast cancer for active smoking is 1.5 in the total
sample, 1.9 in slow acetylators, and 1.0 in rapid acetylators.
That is, these relative risks are consistent with previous
reports of active smoking and breast cancer from studies
lacking information on acetylation status and passive smok-
ing (5) as well as with the findings of Ambrosone et al. (3).
Thus, going back to the two reasons for concern men-
tioned above, it seems that under a reasonable set of as-
sumptions, the hypothesis of a gene-smoking interaction
can reconcile the apparently divergent body of epidemio-
logic evidence relating tobacco smoke to breast cancer.
Moreover, the absence of a dose response may reflect the
fact that genetically susceptible women can develop breast
cancer as a result of exposure to a relatively low dosage of
tobacco carcinogens. This genetic susceptibility may stem
from the slow variant of NAT2, from another polymor-
phism, or, most probably, from a more complex, polygenic
effect.
Whidden (2) suggests that previous studies should be
reanalyzed, taking into account the contamination of the
reference group with passive smokers. We caution that this
is only one facet of the problem, the other being the validity
of the exposure assessment to passive and active smoking.
We recommend considering as passive smokers only those
subjects who have been exposed to other people's smoke for
at least 1 hour per day for at least 1 year and measuring
exposure to active and passive smoking at different periods
during a lifetime.
Whidden (2) also asks whether we can provide informa-
tion about the passive exposure of the active smokers. We
have done this analysis (Curtin et al., submitted for publi-
cation): on average, among our population controls who
were active smokers, the cumulative lifetime passive expo-
sure to tobacco smoke was equivalent to 3 hours per day for
25 years. The main sources of exposure were home and
work. These data suggest that a Swiss smoker gets substan-
tial exposure to other people's smoke in addition to the
smoke inhaled from her own cigarettes.
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